|
- R D-Driven and AI-Powered Biopharma Company | Sanofi
Sanofi is a research development-driven, AI-powered healthcare biopharma company committed to improving lives through innovative medicines vaccines
- Sanofi Pharmaceuticals - Healthcare Innovations | Sanofi USA
Discover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments
- Sanofi - Wikipedia
Sanofi S A is a French multinational pharmaceutical and healthcare company headquartered in Paris, France The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers
- Working at Sanofi
Take the most important step in your career: help us change the lives of people, families, and communities for the better Why Sanofi? Discover new opportunities to grow, find your perfect role This is an incredibly exciting time to be in biopharma
- Sanofi to invest at least $20 billion in the US through 2030, growing . . .
"Sanofi's 13,000 US-based employees are pioneering the research and development of first- and best-in-class medicines across numerous therapeutic areas Our expected investments in the US will be substantial and will help ensure the production of key medicines in the US "
- Our Company: Committed to Improving Peoples Lifes | Sanofi
We are an R D driven, AI-powered biopharma company committed to improving people’s lives and creating compelling growth Our team is guided by one purpose: we chase the miracles of science to improve people’s lives We want to build a healthier, more resilient world
- Our Company - Sanofi U. S.
Learn about Sanofi, a leading global pharmaceutical company in the US, advancing specialty care, vaccines, and consumer healthcare
- Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to . . .
Upon completion of the transaction, Sanofi’s Ridgefield facility will become part of Thermo Fisher's pharma services business within its Laboratory Products and Biopharma Services segment
|
|
|